SKI Market

A+| A| A-|

Indian Indices

Sensex

74,890.36 114.62
( 0.15%)

Global Indices

Nasdaq

51,069.65 379.68
(0.75%)

Dow Jones

7,605.10 20.47
(0.27%)

Hang Seng

66,385.32 1,692.20
(2.62%)

Nikkei 225

10,420.12 -5.84
(-0.06%)

Forex

USD-INR

95.93 0.16
(0.16%)

EUR-INR

111.54 0.10
(0.09%)

GBP-INR

128.71 -0.01
(-0.01%)

JPY-INR

0.60 0.00
(0.17%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Bal Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524824

INE083D01012

65.3864135

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BALPHARMA

21.29

143.69

EPS(TTM)

Face Value()

Div & Yield %

4.24

Back

Sparc Electrex reports standalone net loss of Rs 0.05 crore in the September 2025 quarter

Nov 16,2025

Net loss of Sparc Electrex reported to Rs 0.05 crore in the quarter ended September 2025 as against net profit of Rs 0.02 crore during the previous quarter ended September 2024. Sales declined 90.30% to Rs 0.13 crore in the quarter ended September 2025 as against Rs 1.34 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	0.13	1.34	-90
OPM %	-353.85	3.73	-
PBDT	-0.05	0.02	PL
PBT	-0.05	0.02	PL
NP	-0.05	0.02	PL

74,890.36 114.62 ( 0.15%)

51,069.65 379.68 (0.75%)

7,605.10 20.47 (0.27%)

66,385.32 1,692.20 (2.62%)

10,420.12 -5.84 (-0.06%)

95.93 0.16 (0.16%)

111.54 0.10 (0.09%)

128.71 -0.01 (-0.01%)

0.60 0.00 (0.17%)